THE NICKLES GROUP, LLC

Lobbying for JAZZ PHARMACEUTICALS, INC. · Pharmaceutical company.

Filing 2nd Quarter - Report

2nd Quarter (Apr 1 - June 30) 2026 · Pennsylvania · House · Senate · $50,000.00 income · posted Jul 20, 2026

Lobbying activity 2

Medicare/Medicaid

Issues related to Most Favored Nation drug pricing. Issues related to orphan drugs.

Trade (domestic/foreign)

Issues related to tariffs.

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.